Proactive investorsLogo Proactive Investors Germany Website

Search field
Get Adobe Flash Player Download
Flash
Player ►

And
Enable
Javascript

Additional information
Weitere Informationen
Markt: AIM
Sektor: Freizeit
EPIC: IMM
Nachrichten:
Website: ImmuPharma PLC
weitere Artikel:

ImmuPharma PLC

ImmuPharma plc is a drug discovery and development company. The Company, along with its subsidiaries, is principally engaged in investing in pharmaceutical research and development companies. The Company has operations in Mulhouse, France and Basle, Switzerland. The ImmuPharma plc focuses to develop drugs to treat serious medical conditions. It has five drugs in development to treat: lupus, cancer, severe pain, highly resistant infections, such as methicillin-resistant staphylococcus aureus (MRSA) and inflammatory and allergic disorders. Its wholly owned subsidiaries include ImmuPharma (UK) Limited, which is a holding company; ImmuPharma (France) SA, which is engaged in pharmaceutical research and development, and ImmuPharma AG, which is engaged in pharmaceutical research and development.

Bitte klicken Sie hier um künftige Artikel über ImmuPharma PLC zu bekommen.
You need the Flash Player version 8.0.0.0 or higher and a JavaScript enabled browser to view this content